Pillstats
Labeler · US market

Sumitomo Pharma America, Inc.

Sumitomo Pharma America, Inc. is a US drug labeler with US FDA registrations covering 12 drug concepts (11 currently active) across 53 packages. It is currently the only active US supplier of 5 drugs. The company files with FDA under 2 name variants, merged into this profile.

Also files as: Sumitomo Pharma Co., Ltd.

ACTIVE — US
openFDA · updated weekly
Labeler codes38217 · 63402 · 72359 · 72974 · 73336
Active drugs11
Registrations23 active / 24
Packages53
Sole supplier of5 drugs

Portfolio12 drugs · US

Every drug concept this labeler has US registrations for, by package count.

DrugTypeNDCsPackagesStatus
Lurasidone Hydrochloride
tablet, film coated
rx525SUPPLYING
Eslicarbazepine Acetate
tablet
rx48SUPPLYING
Lurasidone Hydrochloride
tablet, film coated
other55SUPPLYING
Relugolix
tablet, film coated
rx13SUPPLYING
Vibegron
tablet, film coated
rx13SUPPLYING
Relugolix, Estradiol Hemihydrate, And Norethindrone Acetate
tablet, film coated
rx12SUPPLYING
Meropenem
powder
other22SUPPLYING
Lurasidone Hydrochloride
powder
other11SUPPLYING
Zonisamide
powder
other11SUPPLYING
Eslicarbazepine Acetate
kit
rx11SUPPLYING
Allogenic Thymocyte-Depleted Thymus Tissue-Agdc
implant
rx11SUPPLYING
Droxidopa
powder
other11DISCONTINUED